Development of Rational Drug Combinations with Investigational Targeted Agents

  • Clark A
  • Ellis M
  • Erlichman C
  • et al.
7Citations
Citations of this article
15Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

This manuscript explores specific examples and criteria in which an alternative regulatory process to the existing combination rule would be appropriate and feasible and thus could be adopted by developers.

Cite

CITATION STYLE

APA

Clark, A., Ellis, M., Erlichman, C., Lutzker, S., & Zwiebel, J. (2010). Development of Rational Drug Combinations with Investigational Targeted Agents. The Oncologist, 15(5), 496–499. https://doi.org/10.1634/theoncologist.2009-0262

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free